- Home
- BACK vs DRMA Comparison
BACK vs DRMA Comparison
Compare BACK & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACK
- DRMA
- Stock Information
- Founded
- BACK 2000
- DRMA 2014
- Country
- BACK United States
- DRMA United States
- Employees
- BACK N/A
- DRMA N/A
- Industry
- BACK Medical Specialities
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- BACK Health Care
- DRMA Health Care
- Exchange
- BACK Nasdaq
- DRMA Nasdaq
- Market Cap
- BACK 2.1M
- DRMA 1.7M
- IPO Year
- BACK 2019
- DRMA 2021
- Fundamental
- Price
- BACK $1.02
- DRMA $1.12
- Analyst Decision
- BACK
- DRMA Strong Buy
- Analyst Count
- BACK 0
- DRMA 1
- Target Price
- BACK N/A
- DRMA $6.00
- AVG Volume (30 Days)
- BACK 36.3K
- DRMA 85.2K
- Earning Date
- BACK 11-26-2024
- DRMA 11-13-2024
- Dividend Yield
- BACK N/A
- DRMA N/A
- EPS Growth
- BACK N/A
- DRMA N/A
- EPS
- BACK N/A
- DRMA N/A
- Revenue
- BACK N/A
- DRMA N/A
- Revenue This Year
- BACK N/A
- DRMA N/A
- Revenue Next Year
- BACK N/A
- DRMA N/A
- P/E Ratio
- BACK N/A
- DRMA N/A
- Revenue Growth
- BACK N/A
- DRMA N/A
- 52 Week Low
- BACK $1.00
- DRMA $1.11
- 52 Week High
- BACK $7.75
- DRMA $13.35
- Technical
- Relative Strength Index (RSI)
- BACK 35.53
- DRMA 34.78
- Support Level
- BACK $1.00
- DRMA $1.22
- Resistance Level
- BACK $1.35
- DRMA $1.54
- Average True Range (ATR)
- BACK 0.10
- DRMA 0.12
- MACD
- BACK -0.01
- DRMA -0.01
- Stochastic Oscillator
- BACK 5.68
- DRMA 2.35
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.